Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT
卡非佐米、来那度胺和地塞米松联合治疗后行第二次自体干细胞移植(ASCT)是治疗首次复发性多发性骨髓瘤的有效策略:一项由欧洲骨髓移植协会(EBMT)慢性恶性肿瘤工作组开展的研究。
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-023-02048-7
Tilmont, Rémi; Yakoub-Agha, Ibrahim; Eikema, Diderik-Jan; Zinger, Nienke; Haenel, Mathias; Schaap, Nicolaas; Arroyo, Concepcion Herrera; Schuermans, Christine; Besemer, Britta; Engelhardt, Monika; Kuball, Jürgen; Michieli, Mariagrazia; Schub, Natalie; Wilson, Keith M O; Bourhis, Jean Henri; Mateos, Maria Victoria; Rabin, Neil; Jost, Edgar; Kröger, Nicolaus; Moraleda, José M; Za, Tommaso; Hayden, Patrick J; Beksac, Meral; Mclornan, Donal; Schönland, Stefan; Manier, Salomon
肿瘤
发育与干细胞
干细胞
肿瘤免疫
多发性骨髓瘤
ASC
骨髓瘤
细胞生物学